Dexrazoxane for Injection 250 mg (Dexrazoxane POWDER FOR SOLUTION) 250 MG

Dexrazoxane for Injection 250 mg is a powder for solution used for specific medical conditions. This intravenous medication is manufactured by Juno Pharmaceuticals Corp. in Canada.

Strength

250 MG

Manufacturer / TM Owner

JUNO PHARMACEUTICALS CORP.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Dexrazoxane for Injection 250 mg is generally used to reduce the risk of heart problems caused by certain chemotherapy drugs. It is administered intravenously and is often prescribed to patients undergoing specific cancer treatments. The primary use of dexrazoxane is to protect the heart from the damaging effects of chemotherapy, making it a crucial component in some treatment protocols.

Side Effects

Common effects of dexrazoxane may include nausea, vomiting, and fatigue. Some patients might experience fever or chills. These effects can vary from person to person, and not everyone will experience them. It is important to discuss any concerns with a healthcare provider.

Precautions & Warnings

Dexrazoxane should be handled with care and administered by a healthcare professional. It is essential to follow the prescribed dosage and administration guidelines. Patients should inform their healthcare provider about any allergies or medical conditions before starting treatment. Proper storage and handling are crucial to maintain the effectiveness of the medication.

Avoid Interactions

Dexrazoxane may interact with other medications, including certain chemotherapy drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect the way dexrazoxane works, so it is advisable to discuss any concerns with a healthcare professional.

References

Frequently Asked Questions

Dexrazoxane is primarily used to reduce the risk of heart problems caused by certain chemotherapy drugs.

Dexrazoxane is administered intravenously as a powder for solution.

Common side effects may include nausea, vomiting, fatigue, and fever or chills.

Dexrazoxane for Injection is manufactured by Juno Pharmaceuticals Corp. in Canada.

Yes, dexrazoxane may interact with other medications, including certain chemotherapy drugs.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.